| Primary information |
|---|
| ID | 17171 |
| Uniprot ID | P02652 |
| Description | Apolipoprotein A-II (Apo-AII) (ApoA-II) (Apolipoprotein A2) [Cleaved into- Proapolipoprotein A-II (ProapoA-II); Truncated apolipoprotein A-II (Apolipoprotein A-II(1-76))] |
| Organism | Homo sapiens |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Primates; Haplorrhini; Simiiformes; Catarrhini; Hominoidea (apes); Hominidae (great apes); Homininae; Homo; Homo sapiens (Human) |
| Subcellular Location | Secreted |
| Developmental Stage | NA |
| Similarity | NA |
| Tissue Specificity | Plasma; synthesized in the liver and intestine. |
| Post Translational Modification | Phosphorylation sites are present in the extracellular medium. |
| Function | May stabilize HDL (high density lipoprotein) structure by its association with lipids; and affect the HDL metabolism. |
| Length | 100 |
| Molecular Weight | 11175 |
| Name | Proapolipoprotein A-II |
| Sequence | LVRRQAKEPCVESLVSQYFQTVTDYGKDLMEKVKSPELQAEAKSYFEKSKEQLTPLIKKAGTELVNFLSYFVELGTQPATQ |
| Sequence map | 20-40 |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | Q8WTV0 |
| Domain | NA |
| Pharmaceutical Use | NA
|